Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ion Beam Applications SA IBA ( (GB:0GZK) ) has issued an announcement.
IBA has disclosed a transparency notification under Belgian securities law after investment firm Axxion S.A. crossed the 1% shareholding threshold in the company at the start of 2026. Following a recent acquisition or disposal of securities or voting rights, Axxion now holds 632,728 voting rights in IBA, representing 1.56% of the company’s voting rights, signaling a modest but notable institutional stake that slightly broadens IBA’s shareholder base without altering control of the company.
The most recent analyst rating on (GB:0GZK) stock is a Hold with a EUR12.00 price target. To see the full list of analyst forecasts on Ion Beam Applications SA IBA stock, see the GB:0GZK Stock Forecast page.
More about Ion Beam Applications SA IBA
Ion Beam Applications SA (IBA), based in Louvain-la-Neuve, Belgium, is the world leader in particle accelerator technology and the leading supplier of proton therapy equipment and services, used for advanced cancer radiation treatment, as well as solutions for industrial sterilization, radiopharmaceuticals and dosimetry. The company employs around 2,100 people worldwide, is certified as a B Corporation for meeting high social and environmental standards, and is listed on Euronext under the ticker IBAB.
Average Trading Volume: 27,138
Current Market Cap: €414.6M
See more insights into 0GZK stock on TipRanks’ Stock Analysis page.